Brain aneurysm is a bulging or balloon-like growth in humans, which appears typically in the areas where large arteries branch into smaller ones, generally observed at the base of the brain. Brain aneurysm is also known as cerebral aneurysm or intracranial aneurysm. Aneurysm has the potential to rupture, which causes bleeding in the surrounding sub-arachnoid space, generally resulting in brain damage or stroke. Sometimes, it may lead to even death. Brain aneurysm rarely has any symptoms until the swelling ruptures. However, double vision, localized headache, and cranial nerve palsy are a few symptoms of mass effect of brain aneurysm on adjacent neurological structures. Key causes of brain aneurysm include heredity, aging, atherosclerosis infection, and brain injury.

Ruptured brain aneurysm is a critical condition and in a few cases, it could be fatal. It is generally diagnosed with the help of magnetic resonance angiography, cerebral angiography, or computed tomography (CT) scan. Brain aneurysm is one of the leading causes of hemorrhagic stroke. According to UCSF Medical Center, approximately 3%–5% of people in the U.S. are affected by brain aneurysm every year. It is mostly prevalent in adults aged 35–60 years. It is also observed to be more prevalent in women than men, with a prevalence ratio of 3:2. According to the Brain Aneurysm Foundation, 1 in 50 people in the U.S. have brain aneurysm. Of these, 40% of the cases are fatal and 60% of the cases suffer from a permanent neurological defect. Every year, 500,000 people die of brain aneurysm across the world. Of these, 50% people are aged 50 years or below. According to a research study conducted by Karger Journal, the rate of mortality after the conservative treatment in the first few months is 50%–60%.

The Federal government spends a mere US$ 0.83 per afflicted person per year on brain aneurysm research. Significant developments over the last few years with volumes of supporting data, rise in the adoption of advanced technologies for the diagnosis and treatment of brain aneurysm, and the genetic factor responsible for occurrence of the disease are factors fueling the brain aneurysm treatment market. On the other hand, high cost of the treatment and unrecognized symptoms of the brain aneurysm are considered to be major restraining factors for the market.

Based on treatment type, the brain aneurysm treatment market has been segmented into medication and surgery. The surgery segment has been sub-segmented into endovascular coiling, flow diverters, surgical clipping, and others. The flow diverters sub-segment has been further divided into silk flow diverters, pipeline embolization devices, and surpass flow diverters. The medication segment has been sub-segmented into analgesics, antiemetics, anti-seizure medications, calcium channel blockers, antacids, and others.

Based on type, the brain aneurysm treatment market has been segmented into unruptured aneurysm and ruptured aneurysm. The ruptured aneurysm segment holds a major market share, due to prominent symptoms of ruptured aneurysm and ease of diagnosis. However, advancing technologies in diagnostics and growing initiatives for regular health screenings are anticipated to propel the unruptured aneurysm segment during the forecast period. Based on end-user, the market has been segmented into hospitals, specialty clinics, and others.

Based on geography, the brain aneurysm treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the global market during the forecast period, due to availability of advanced screening processes, high health care expenditure, and rise in awareness about the disease in the region. Asia Pacific is expected to be a rapidly growing market for brain aneurysm treatment from 2017 to 2025, due to the rising number of patients, improved diagnosis, and developing health care infrastructure in the region.

Some of the key players operating in the brain aneurysm treatment market are Raumedic AG, DePuy Synthes, Integra Life Sciences Corporation, Orsan Medical Technologies, Spiegelberg GmbH, MicroPort Scientific Corporation, Medtronic Plc., and Codman & Shurtleff, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Brain Aneurysm Treatment Market

Pre Book